Mr. Rydin has held several executive sales roles in the medical device industry, including positions at DePuy Spine, Orquest and Symphonix Devices.
Most recently, he operated as chief sales officer of Ellipse Technologies before NuVasive acquired the company for $410 million in 2016. Prior to the acquisition, he served as president of global sales at NuVasive.
Mr. Moody has served as a partner at Frazier Healthcare Ventures, a private equity firm with more than $2 billion under management.
For eight of his 10 years at the company, he co-led the medical device team at the company, focusing on orthopedics, sports medicine and neurostimulation, according to his LinkedIn profile.
More articles on devices:
Medical freeze placed on NuVasive spinal rods in UK, Ireland
Michigan Head and Spine Institute surgeons take 45% pay cut during COVID-19
Nonsurgical procedures, mediocre care & COVID-19: 3 spine surgeons on the biggest threat to their practice
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
